Prevalence of Polycystic Ovary Syndrome in Reproductive-Age Women in Nicaragua, 2023

    September 2025 in “ Revista de Ciencias de la Salud de la Universidad Americana ”
    Ivonne Dessireé Leytón Padilla, María Laura Rivas Meza, Ana Isabel Yanguas Cross, Andrea Javiera Pérez Zelaya
    A study conducted at the Medical Clinic of the American University in Nicaragua assessed the prevalence of Polycystic Ovary Syndrome (PCOS) among 56 women of reproductive age. The study found that 30.4% of the participants were diagnosed with PCOS based on clinical criteria and ultrasound findings, which is significantly higher than the international prevalence rates of 8-13%. The study highlighted that 23.2% of the women exhibited androgenic alopecia, and 41.1% showed evidence of PCOS through pelvic ultrasound. The findings suggest a higher prevalence of PCOS in the studied population, particularly among Hispanic women, and emphasize the underdiagnosis of the condition globally.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 21 results

      community C’est terrible - at my wits end

      in Female  450 upvotes 2 years ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 7 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  57 upvotes 2 years ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

    Similar Research

    6 / 1000+ results